Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms

Clinical trial NCT05455294 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05455294
Sponsor: Jacqueline Garcia, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloid Malignancy Myelodysplastic Syndromes Myelofibrosis Acute Myeloid Leukemia Myeloproliferative Neoplasm

Start date: 2022-07-18
Primary completion: 2024-04-17
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.